Literature DB >> 20486733

Leflunomide in combination therapy for rheumatoid arthritis.

Ruth L Savage1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20486733     DOI： 10.2165/11532390-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  15 in total

1.  Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story.

Authors:  J S Smolen; W B Graninger; P Emery
Journal:  Rheumatology (Oxford)       Date:  2000-07       Impact factor: 7.580

2.  Pancytopenia associated with leflunomide and methotrexate.

Authors:  Richard L Hill; Duncan J Topliss; Patrick M Purcell
Journal:  Ann Pharmacother       Date:  2003-01       Impact factor: 3.154

3.  Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.

Authors:  Joel M Kremer; Mark C Genovese; Grant W Cannon; Jacques R Caldwell; John J Cush; Daniel E Furst; Michael E Luggen; Ed Keystone; Michael H Weisman; William M Bensen; Jeffrey L Kaine; Eric M Ruderman; Patricia Coleman; David L Curtis; Elliot J Kopp; Seth M Kantor; Jonathan Waltuck; Herbert B Lindsley; Joseph A Markenson; Vibeke Strand; Bruce Crawford; Indra Fernando; Karen Simpson; Joan M Bathon
Journal:  Ann Intern Med       Date:  2002-11-05       Impact factor: 25.391

4.  Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.

Authors:  Samy Suissa; Marie Hudson; Pierre Ernst
Journal:  Arthritis Rheum       Date:  2006-05

5.  Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports.

Authors:  R L Savage; J Highton; I W Boyd; P Chapman
Journal:  Intern Med J       Date:  2006-03       Impact factor: 2.048

Review 6.  Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature.

Authors:  G Searles; R J McKendry
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

7.  Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.

Authors:  M E Weinblatt; J M Kremer; J S Coblyn; A L Maier; S M Helfgott; M Morrell; V M Byrne; M V Kaymakcian; V Strand
Journal:  Arthritis Rheum       Date:  1999-07

8.  Leflunomide induced acute interstitial pneumonia.

Authors:  Michio Takeishi; Yuji Akiyama; Haruhiko Akiba; Daisuke Adachi; Motoharu Hirano; Toshihide Mimura
Journal:  J Rheumatol       Date:  2005-06       Impact factor: 4.666

9.  Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.

Authors:  Yasuyuki Kamata; Hiroyuki Nara; Takeshi Kamimura; Kengo Haneda; Masahiro Iwamoto; Junichi Masuyama; Hitoaki Okazaki; Seiji Minota
Journal:  Intern Med       Date:  2004-12       Impact factor: 1.271

Review 10.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606
View more
  2 in total

Review 1.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

2.  Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial.

Authors:  Chi Zhang; Daogang Guan; Miao Jiang; Chao Liang; Li Li; Ning Zhao; Qinglin Zha; Wandong Zhang; Cheng Lu; Ge Zhang; Jian Liu; Aiping Lu
Journal:  Chin Med       Date:  2019-08-02       Impact factor: 5.455
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.